Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
1. Absci Corporation's shares fell 9.4% following earnings report. 2. Quarterly loss of 25 cents per share missed expectations. 3. Sales of $665,000 also missed analyst estimates of $1.778 million. 4. This performance reflects unchanged results from the previous year. 5. Broader market futures rose, contrasting with ABSI's decline.